IFNAR2 and COVID-19: In addition, our data show reduced levels of plasmacytoid DCs (pDC), which produce high levels of type I interferon36 and increased expression of IFNAR2 on several myeloid cell subsets at steady-state in individuals recovered from severe COVID-19, pointing towards impaired type I interferon responsiveness.